Puriton had the tendency of decreasing expressions of Th1 cell-related cytokines such as IFN- by So-Hyeon Bok (8066696)

Forest plots illustrate the mean difference in; (A) creatinine clearance, (B) eGFR, (C) BUN, and (D) shows relative risk in ARF. by Mohamed R. Abdelraouf (21501468)

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

No significant diurnal rhythmicity of short chain fatty acids in the blood was observed. by Weiran Shan (16969688)

SDI-based age-standardized rates of DALYs and ASDR for IHD attributable to HSBP. by Zhenhua Zhuang (11192745)

Subjects:

Effect of alkali-stress to chlorophyll fluorescence parameters compared to control treatment. by Zeyu Jiang (5094320)

Subjects:

Effect of alkali-stress on photosynthetic pigments of hemp seedlings compared to control treatment. by Zeyu Jiang (5094320)

Subjects:

Effect of alkali-stress on physiological indices of antioxidant system compared to control treatment. by Zeyu Jiang (5094320)

Subjects:

Effects of MC treatment on protein expression in DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

Subjects:

Effects of MC treatment on symptoms and histological changes in DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

Subjects:

Clinical characteristics. by Clemens Plattner (21567706)

“…FHD was associated with increased risk for neuropathy (HR 1.41 [95%CI 1.11–1.81]) but decreased risk for macrovascular disease (HR 0.84 [95%CI 0.71–0.99]). …”

Changes in the distribution of average sleep duration. by Hea Ree Park (10769827)

Subjects:

Changes in symptoms of insomnia and excessive daytime sleepiness during the COVID-19 pandemic by age. by Hea Ree Park (10769827)

Subjects:

Changes in sleep patterns before versus during the COVID-19 pandemic by age. by Hea Ree Park (10769827)

Subjects:

Sociodemographic characteristics. by Hea Ree Park (10769827)

Subjects: